UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022642
Receipt number R000026101
Scientific Title Early diagnosis of Alzheimer's disease using resting-state fMRI
Date of disclosure of the study information 2016/08/01
Last modified on 2017/01/12 11:35:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early diagnosis of Alzheimer's disease using resting-state fMRI

Acronym

Resting-state fMRI in Alzheimer's disease

Scientific Title

Early diagnosis of Alzheimer's disease using resting-state fMRI

Scientific Title:Acronym

Resting-state fMRI in Alzheimer's disease

Region

Japan


Condition

Condition

Alzheimer'd disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the usefulness of re-fMRI in Alzheimer's disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

regional brain function measured by rs-fMRI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Oral administration of 75g glucose

Interventions/Control_2

nothing administgration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

AD patients
1. The subjects who have intention to
participate in this study, and signed
informed consent.
2. Male and female subjects of >=60 and <90 years, old.
Healthy sujbects
1. The subjects who have intention to
participate in this study, and signed
informed consent.
2. Male and female subjects of >=20 and <90 years, old.

Key exclusion criteria

1. The subjects with a history of brain
diseases, excluding than cerebellar
diseases.
2. The subjects who are prescribed a
medication for the central nervous
system.
3. The subject who have chronic
dysfunction in the organs.
4. Pregnant or woman who has a
chance of pregnant.
5. The subjects who were judged by
the clinical investigator to be
inappropriate as a participant in this
study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Ishibashi

Organization

Tokyo Metropolitan Institute of Gerontology

Division name

Research Team for Neuroimaging

Zip code


Address

35-2 Sakae-cho, Itabashi-ku, Tokyo

TEL

03-3964-3241

Email

ishibashi@pet.tmig.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroko Sato

Organization

Tokyo Metropolitan Institute of Gerontology

Division name

Research Team for Neuroimaging

Zip code


Address

35-2 Sakae-cho, Itabashi-ku, Tokyo

TEL

03-3964-3241

Homepage URL


Email

sato@pet.tmig.or.jp


Sponsor or person

Institute

Tokyo Metropolitan Institute of Gerontology

Institute

Department

Personal name



Funding Source

Organization

Tokyo Metropolitan Institute of Gerontology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 07 Day

Last modified on

2017 Year 01 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026101


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name